期刊文献+

雌激素影响卵巢癌细胞系COC1顺铂耐药的相关机制

Relative mechanism about influence of estrogen on cisplatin-resistance in ovarian cancer cell line COC1/DDP
下载PDF
导出
摘要 目的研究雌激素对顺铂诱导卵巢癌细胞系COC1和COC1/DDP凋亡的影响。方法运用细胞培养、MTT、原位标记法、流式细胞术和免疫组化等方法,采取雌激素预先作用卵巢癌COC1和COC1/DDP细胞16h,随后与顺铂共同培养诱导凋亡方式,动态地观察雌激素对顺铂诱导这两个细胞系凋亡影响和此过程中细胞周期分布和p53蛋白表达的改变。结果雌激素促进顺铂诱导的COC1和COC1/DDP细胞凋亡,引起细胞周期由G2到S期的转变,p53蛋白对雌激素作用无明显影响。结论处于细胞周期顺铂不敏感期的卵巢癌细胞可能与其耐药有关,雌激素可增加耐药的COC1/DDP细胞顺铂敏感性。 [Objeetive] To study the estradiol -effect on cisplatin-induced apoptosis in ovarian cancer cell line COC1 and COC1/DDP. [Methods] By using cell culture, MTT, in situ cell apoptosis detection, flow cytometry and immunohistochemistry technologies, the influence of estradiol (E2) on cisplatin-induced apoptosis in COC1 and COC1/DDP cell line and the change of cell cycle distrubtion and p53 protein expression were observed during cell culture where the estradiol affected the COC1 and COC1/DDP before adding cisplatin. [Results] Estradiol accelerated the cisplatin-induced apoptosis of COC1 and COG1/DDP cell lines and brought the change of cell cycle distmtion from G2 to S.At the same time, p53 protein had no obvious effect on the action of estradiol. [Conclusion] Ovarian caner in cell cycle when showing no sensitive to cisplatin may be connected with cisplatin-resistance. Estradiol can increase the cisplatin-sensitivity in resistant COClfDDP cell.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第13期1974-1977,1982,共5页 China Journal of Modern Medicine
关键词 顺铂耐药 雌激素 凋亡 细胞周期 人卵巢癌 cisplafin-resistance apoptosis Estrogen cell cycle human ovaran cancer
  • 相关文献

参考文献9

  • 1ROHDE S,KOVACS AF,TUROWSKI B,et al.Intra-arterial high-dose chemotherapy with Cisplatin as part of a palliative treatment concept in oral cancer[J].AJNR Am J Neuroradiol,2005,26(7):1804-1809.
  • 2YANG Y,SHEN K,LANG JH.Influence of ertrogen on the epithelial ovarian cancer cell lines in vitro[J].Chin J Obstet Gynecol,2000,35(3):172-174.
  • 3MIRZA A,WU Q,WANG L,MCCLANAHAN T,et al.Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression[J].Oncogene,2003,22(23):3645 -3654.
  • 4KRASNA L,NETIKOVA I,CHALOUPKOVA A,et al.Assessment of in vitro drug resistance of human breast cancer cells subcultured from biopsy specimens[J].Anticancer Res,2003,23(3B):2593-2599.
  • 5DAY JM,NEWMAN SP,COMNINOS A,et al.The effects of2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells[J].J Steroid Biochem Mol Biol,2003,84(2-3):317-325.
  • 6VERONESI A,DE GIACOMI C,MAGRI MD,et al.Familial female breast cancer:characteristics and outcome of BRCA 1-2positive and negative cases[J].BMC Cancer,2005,5(1):70.
  • 7HE Q,LIANG CH,LIPPARD SJ.Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin[J].Proc Natl Acad Sci U S A,2000,97(11):5768-5772.
  • 8WANG W,TAKOMOTO R,RASTINEJAD F,et al.Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding[J].Mol Cell Biol,2003,23(6):2171-2181.
  • 9ANGELA R,WEN H.W,ANNETTE S,et al.Correction of p53mutation with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer[J].Clinical Cancer Res,2001,7:2984-2997.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部